# Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment

> **NCT00417833** · PHASE2,PHASE3 · TERMINATED · sponsor: **Asociación para Evitar la Ceguera en México**

## Conditions studied

- Diabetic Proliferative Retinopathy
- Vascular Vein Oclussion
- Choroidal Neovascularization

## Interventions

- **DRUG:** Intravitreal Bevacizumab

## Key facts

- **NCT ID:** NCT00417833
- **Lead sponsor:** Asociación para Evitar la Ceguera en México
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** — (—)
- **Why stopped:** Poor accrual
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00417833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00417833, "Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00417833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*